NCT05258838Completed
Tunisian National Registry on Psoriasis
Source: ClinicalTrials.gov · Last updated 17 Feb 2025
Brief summary (registry, in English)
National cross-sectional multicentric study to describe the epidemiological characteristics of patients with Psoriasis in Tunisia
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1100 (actual)
- First submitted
- 14 Feb 2022
- Start date
- 12 Jul 2022
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Dacima Consulting
- Diseases
- Psoriasis
- NCT number
- NCT05258838
What you commit to
- Study type: Observational
- Participants enrolled: 1100
- From 12 Jul 2022 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any dermatology disease other than psoriasis
Who the study is looking for
- Patients with psoriasis
- Informed and written consent
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Société Tunisienne de Dermatologie et de Vénéréologie Coordinator of this site? Confirm its status | Tunis | Tunisia | Unknown status |
Related publications
- Severity of Psoriasis in Tunisia: Cross-Sectional Results From the National PsoTReg Registry.Int J Dermatol · 2026 · PMID 42452943
This page is information, not medical advice. Discuss any trial with your doctor.